Apollomics (APLM) Liabilities and Shareholders Equity (2022 - 2025)

Apollomics (APLM) posted quarterly Liabilities and Shareholders Equity of $6.7 million for Q4 2025, down 48.74% year-on-year from $13.1 million in Q4 2024, and down 39.62% on a QoQ basis from $11.1 million in Q2 2025.

Apollomics (APLM) Liabilities and Shareholders Equity (2022 - 2025) Analysis & Trends

Apollomics (APLM) has reported Liabilities and Shareholders Equity for 4 consecutive years, with $6.7 million the latest figure, recorded in Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 48.74% year-over-year to $6.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $51.7 million (down 64.69% YoY) and the FY2025 annual result came in at $6.7 million, down 48.74% from the prior year.
  • Liabilities and Shareholders Equity fell to $6.7 million in Q4 2025 per APLM's latest filing, from $11.1 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for APLM reached as high as $76.5 million in Q4 2022 and fell as low as $6.7 million in Q4 2025.
  • A 4-year average of $34.4 million and a median of $20.8 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity tumbled 46.08% — and 2024, when it plunged 70.85%.
  • Year by year, Liabilities and Shareholders Equity stood at $76.5 million in 2022, then plunged by 46.08% to $41.2 million in 2023, then tumbled by 68.23% to $13.1 million in 2024, then sank by 48.74% to $6.7 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $6.7 million, $11.1 million, and $13.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 311.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 78.88 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 8.55 Bn
4 NuCana 279.75 Bn 279.75 Bn - 39.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 26.48 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 40.87 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 811.27 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 10.03 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.25 Bn
10 Apollomics 2.66 Bn 2.66 Bn - 6.71 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.71 Mn
Jun 30, 2025 11.12 Mn
Dec 31, 2024 13.10 Mn
Jun 30, 2024 20.81 Mn
Dec 31, 2023 41.23 Mn
Jun 30, 2023 71.38 Mn
Dec 31, 2022 76.48 Mn